Enoxaparin Thromboprophylaxis in Children Hospitalized for COVID-19: A Phase 2 Trial.

Anthony A Sochet,John M Morrison,Julie Jaffray,Nihal Godiwala,Hope P Wilson,Courtney D Thornburg,Rukhmi V Bhat,Ayesha Zia,Courtney Lawrence,Sapna R Kudchadkar,Frances Hamblin,Christopher J Russell,Michael B Streiff,Alex C Spyropoulos,Ernest K Amankwah,Neil A Goldenberg

Pediatrics（2022）

引用 13|浏览4

暂无评分

摘要

Among children hospitalized for COVID-19, thromboprophylaxis with twice-daily enoxaparin appears safe and warrants further investigation to assess efficacy.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要